|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash and due from banks | |||||
| Interest-earning deposits | |||||
| Cash and Cash Equivalents | |||||
| Securities available for sale, at fair value | |||||
| Federal Home Loan Bank stock, at cost | |||||
| Loans receivable, net of allowance for credit losses of $4,747 in 2026 and $4,884 in 2025 | |||||
| Premises and equipment, net | |||||
| Accrued interest receivable | |||||
| Bank-owned life insurance | |||||
| Other assets | |||||
| Total Assets | |||||
| Liabilities and Stockholders' Equity | |||||
| Liabilities | |||||
| Deposits: Interest bearing | |||||
| Deposits: Non-interest bearing | |||||
| Total Deposits | |||||
| Long-term debt | |||||
| Advances from borrowers for taxes and insurance | |||||
| Other liabilities and accrued interest payable | |||||
| Total Liabilities | |||||
| Stockholders' Equity | |||||
| Preferred stock, $0.01 par value per share, 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued or outstanding at June 30, 2026 or December 31, 2025 | |||||
| Common stock, $0.01 par value per share, 40,000,000 shares authorized at June 30, 2026 and December 31, 2025; 7,863,818 shares issued and outstanding at June 30, 2026, including 84,829 unvested shares, and 7,836,100 shares issued and outstanding at December 31, 2025, including 80,094 unvested shares | |||||
| Additional paid-in capital | |||||
| Treasury stock, at cost (1,077,342 shares at June 30, 2025 and 1,101,288 shares at December 31, 2024) | |||||
| Unearned shares held by ESOP | |||||
| Unearned shares held by compensation plans | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss | |||||
| Total Stockholders' Equity | |||||
| Total Liabilities and Stockholders' Equity |
Loading...
